Akèy › Skleroderm Difize › Arizona › Phoenix
Etid klinik pou Skleroderm Difize nan Phoenix, AZ
3 etid pou Skleroderm Difize ap chèche patisipan nan sit nan ak bò kote Phoenix (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Ap rekriteFaz 2
- EncompaSSc site in Phoenix, AZ, Phoenix
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Ap rekriteFaz 1
- Mayo Clinic, Phoenix
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Ap rekriteFaz 2
- Artiva Investigational Site Phoenix, Phoenix
Etid Skleroderm Difize nan lòt vil
- New York City, NY8 etid
- Chicago, IL7 etid
- Ann Arbor, MI7 etid
- Durham, NC6 etid
- Los Angeles, CA6 etid
- Baltimore, MD5 etid
- Houston, TX5 etid
- Boston, MA5 etid
- Pittsburgh, PA4 etid
- Kansas City, KS4 etid
- New Orleans, LA4 etid
- Philadelphia, PA4 etid
Lòt etid nan Phoenix
- Kansè kolorektal25 etid
- Kansè nan tete25 etid
- Obèsite23 etid
- Kansè Metastatik20 etid
- Kansè Poumon ki pa ti selil20 etid
- Ensifizyans kadyak18 etid
- Kansè pwostat17 etid
- Kansè (tout kalite)17 etid
- Kansè pankreyas17 etid
- Myelom Miltip16 etid
- Maladi kadyovaskilè16 etid
- Sipwa15 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.